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Abstract
Background: Streptococcus pneumoniae, also called the pneumococcus, is a major bacterial pathogen. Since its
introduction in the 1940s, penicillin has been the primary treatment for pneumococcal diseases. Penicillin
resistance rapidly increased among pneumococci over the past 30 years, and one particular multidrug-resistant
clone, PMEN1, became highly prevalent globally. We studied a collection of 426 pneumococci isolated between
1937 and 2007 to better understand the evolution of penicillin resistance within this species.
Results: We discovered that one of the earliest known penicillin-nonsusceptible pneumococci, recovered in 1967
from Australia, was the likely ancestor of PMEN1, since approximately 95% of coding sequences identified within its
genome were highly similar to those of PMEN1. The regions of the PMEN1 genome that differed from the ancestor
contained genes associated with antibiotic resistance, transmission and virulence. We also revealed that PMEN1
was uniquely promiscuous with its DNA, donating penicillin-resistance genes and sometimes many other genes
associated with antibiotic resistance, virulence and cell adherence to many genotypically diverse pneumococci. In
particular, we describe two strains in which up to 10% of the PMEN1 genome was acquired in multiple fragments,
some as long as 32 kb, distributed around the recipient genomes. This type of directional genetic promiscuity from
a single clone to numerous unrelated clones has, to our knowledge, never before been described.
Conclusions: These findings suggest that PMEN1 is a paradigm of genetic success both through its epidemiology
and promiscuity. These findings also challenge the existing views about horizontal gene transfer among
pneumococci.
Background
Worldwide, over 1.6 million deaths annually are attribu-
ted to the bacterial pathogen Streptococcus pneumoniae,
the ‘pneumococcus’ [1]. This bacterium is a leading cause
of otitis media, sinusitis, pneumonia and meningitis, and
is associated with high mortality rates in the developing
world [1,2]. While many pneumococcal diseases can be
successfully treated with antibiotics such as penicillin
(and other b-lactams), resistance is a major global pro-
blem. The primary pneumococcal penicillin resistance
determinants are three of the six penicillin-binding pro-
tein (pbp) genes, pbp2x, pbp1a and pbp2b. In penicillin-
nonsusceptible pneumococci (PNSP) these genes contain
mosaic sequence blocks differing from those of penicil-
lin-susceptible pneumococci (PSP) by up to 25% nucleo-
tide divergence [3,4]. It is believed that these mosaic
blocks were acquired from closely related viridans strep-
tococci via homologous recombination [3,5].
PNSP were first reported in the late 1960s (in the USA
and Australia) [6,7]. In the late 1970s the first high-level
penicillin-resistant pneumococci were reported in South
Africa [8,9]. Throughout the 1980s and 1990s global peni-
cillin nonsusceptibility rates rocketed, surpassing 50% in
some regions [10]. The selective pressure of antibiotic use
was enormous at this time, as antibiotics were widely used,
even overused, in many countries. This selective pressure
meant that pneumococci with some level of resistance to
penicillin or other antibiotics had a distinct advantage over
susceptible strains, which may have indirectly contributed
to a change in the distribution of pneumococcal capsular
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types (or serotypes, defined by the antigenic polysaccharide
capsule surrounding the cell) [11]. Following the introduc-
tion of a 7-valent pneumococcal conjugate vaccine (PCV7)
in the year 2000 in the USA, there was a substantial reduc-
tion in PNSP levels [12]. Use of PCV7 in children provides
efficacious protection against 7 of the 94 known pneumo-
coccal serotypes [1], including those that were most com-
monly associated with penicillin resistance. Pneumococcal
disease caused by PCV7 type pneumococci has signifi-
cantly declined in countries that have introduced PCV7.
Subsequently, there has been an increase in pneumococcal
disease due to non-PCV7 type pneumococci [13], many of
which are now also penicillin nonsusceptible [14]. 10- and
13-valent pneumococcal vaccines, containing additional
serotypes, have recently been introduced, and continued
surveillance over the next few years will be essential to
determine their effects.
Alongside the increase of PNSP there has been an emer-
gence of predominant and widely distributed pneumococ-
cal clones; 43 important disease-causing clones, many of
which are multidrug-resistant, have been identified by the
Pneumococcal Molecular Epidemiology Network (PMEN)
[15]. The first of these clones was Spain23F-1, here called
PMEN1. This multidrug-resistant pneumococcus predo-
minantly circulates as a vaccine serotype 23F, multilocus
sequence type 81 clone (ST8123F); however, it has also
been associated with several other serotypes, including
both vaccine types and non-vaccine types [16,17]. The first
PMEN1 representative was isolated in Spain in 1984 and
shortly thereafter in the USA [18], the United Kingdom
[16], South Africa [19,20], Hungary [21], and South Amer-
ica [22]. By the late 1990s it was estimated that approxi-
mately 40% of PNSP circulating in the USA were
members of this clone [23] and it continues to circulate
among pneumococcal populations today.
A recent study of approximately 240 pneumococci
representing PMEN1 sequence type (ST)81 and related
clonal variants (all belonging to clonal complex (CC) 81)
showed that there is a considerable amount of genetic
diversity within this lineage. This diversity, which largely
results from hundreds of recombination events, indicates
rapid genomic evolution and presumably allowed rapid
response to selective pressures such as those imposed by
vaccine and antibiotic use [17].
Here we studied a large (n = 426), genetically diverse,
historical and global pneumococcal isolate collection with
the aim to better understand the evolution of penicillin
resistance within this species. We uncovered the impor-
tant contribution of the PMEN1 clone to the emergence
and spread of penicillin-resistant pneumococci and
revealed its genetically highly promiscuous nature.
Furthermore, we have been able to confidently identify the
ancestor of this globally and historically important clone
as being closely related to one of the oldest known PNSP.
Results
PMEN1 pbp promiscuity
Pneumococcal study isolates (Table 1) were assigned to
CCs based on multilocus sequence type (MLST) data.
Isolates within CCs are considered to have shared ances-
try, while those in different CCs are more distantly
related. Within our collection, identical or highly similar,
‘nonsusceptible’ pbp alleles and/or sequence regions were
identified repeatedly among pneumococci belonging to
different CCs. These pbp sequences were those asso-
ciated with the PMEN1 reference strain (GenBank acces-
sion: NC_011900.1, hereafter simply called ‘PMEN1’).
Two isolates, CGSP14 (GenBank accession NC_
010582.1) and the PMEN3 reference strain (GenBank
accession ABGE00000000.1, hereafter called ‘PMEN3’),
representing independent CCs (Table 2), shared identical
pbp2x, pbp1a and pbp2b alleles with PMEN1. Analysis of
the genomic regions flanking these pbp genes showed
that, in fact, much larger regions of the CGSP14 and
PMEN3 genomes (5,362 to 22,104 bp; Figure 1) were iden-
tical or highly similar to that of PMEN1, suggesting these
regions, which conferred penicillin nonsusceptibility, were
acquired from a PMEN1 representative(s) in both cases.
The PMEN2 reference strain, representing another CC
(Table 2), also shared identical regions (225 to 1,034 bp in
length) of all three of its pbp alleles with PMEN1 (the
intervening regions of sequence were different). A total of
12 distinct CCs were represented by isolates sharing iden-
tical pbp sequences in whole or part (119 to 1,376 bp) in
one or two of their pbp alleles to PMEN1, suggesting that
they too were acquired from a PMEN1 representative.
Nine additional CCs were represented by isolates sharing
pbp2x and/or pbp2b regions (199 to 1,436 bp) that differed
from those of PMEN1 by only one or two nucleotide sub-
stitutions, again suggesting possible acquisition from a
PMEN1 representative (see Additional file 1 for pbp allele
and CC information). No other pbp alleles were as widely
distributed as those of PMEN1.
Extensive PMEN1 genomic recombination
Given that the CGSP14 and PMEN3 genomes each con-
tained three large, independent regions that were puta-
tively acquired from PMEN1, we used whole genome
sequence data generated on the Illumina platform to
assess whether other regions of the PMEN1 genome
were also shared by CGSP14 and PMEN3 (both of which
represent multidrug-resistant clones, the latter of which
is also globally distributed). We found that, in fact, 15
regions (1,663 to 32,312 bp, totalling 211,963 bp,
approximately 9.5% of the genome) of the CGSP14 chro-
mosome were identical to those of PMEN1 or differed by
only 1 to 2 nucleotides across a minimum of 7,537 bp
(Figure 2; Additional file 2), and were not identical in any
of four CGSP14 ancestral representative genomes. The
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ancestral representatives (14/5, the PMEN9 reference
strain, ICE13 and ICE570; Table 2) were chosen from
our collection because they represented older and/or
penicillin-susceptible members of the CGSP14 CC and
so likely resembled the true ancestor of the penicillin-
resistant CGSP14. Importantly, this allowed us to identify
and exclude identical sequence that was shared by des-
cent, whereas regions of the CGSP14 genome that dif-
fered from its ancestral representatives but were identical
to those of PMEN1 were most likely acquired from
PMEN1 through the process of recombination. The
ancestral isolates were generally all identical or highly
Table 1 Isolates included in this study
Number of
isolatesa




Denmark (139), USA (48), Germany (6), France (2), India (2), Malaysia (2), Singapore (2), Australia (1),





The Netherlands (6), USA (6), Portugal (5), South Africa (3), Spain (3), Czech Republic (2), Greece (2),
Poland (2), Taiwan (2), Canada (1), Columbia (1), Denmark (1), England (1), Finland (1), France (1),









South Africa (17), Germany (8), Papua New Guinea (2) RH [57,58]
27 (27) 1981-
1991
USA (26), South Africa (1) LM [59]
26 (26) 1977-
1978








Iceland (17) KGK -
9 (9) 1987-
1989
Spain (9) JL [61-65]
8 (8) 1998-
2002
USA (8) ABB -
Total number of isolates = 426 (excluding isolates for which genomic data were retrieved from GenBank; see Materials and methods). aNumber of isolates
selected for pbp nucleotide sequencing (total n = 389). bThe year of one isolate was unknown. Source abbreviations: LML, LM Lambertsen; LM, L McGee; KPK, KP
Klugman; AVG, A von Gottberg; RH, R Hakenbeck; MRJ, MR Jacobs; BWB, BW Beall; KGK, KG Kristinsson; JL, J Liñares; ABB, AB Brueggemann.
Table 2 Pneumococcal isolates discussed in the text
Isolatea Other name(s) Year Serotype Sequence type Clonal complex Penicillin susceptibilityb
PMEN1 ATCC 700669 1984 23F 81 81 I
CGSP14 2004-2005 14 15 15 R
14/5 1967 14 15 15 S
PMEN9 ATCC 700676 1993 14 9 15 S
ICE13 1998 14 9 15 S
ICE570 2002 14 9 15 S
PMEN3 ATCC 700671; SP195 1993 9V 156 156/162 I
9A/1 1962 9A 312 156/162 S
9V/5 1991 9V 162 156/162 S
9V/6 1994 9V 162 156/162 S
PMEN2 ATCC 700670 1988 6B 90 90 I
23F/4 1967 23F 7184 Singleton7184 I
PMEN18 ATCC BAA-340 1997 14 67 66 R
CDC3059-06 2005 19A 199 199 I
CDC0288-04 Unknown 12F 220 218 S
USA18 1999 12F 218 218 S
TIGR4 1991 4 205 205 Unk
aPMEN refers to Pneumococcal Molecular Epidemiology Network reference strains. bS = MIC ≤ 0.06 μg/ml; I = MIC 0.12 to 1 μg/ml; R = MIC ≥ 2.0 μg/ml; Unk =
unknown.
Wyres et al. Genome Biology 2012, 13:R103
http://genomebiology.com/2012/13/11/R103
Page 3 of 12
similar to each other at the genomic regions in question;
sequences from these isolates were also highly similar to
CGSP14 in the regions flanking the putative recombina-
tion imports, confirming their suitability as ancestral
representatives.
Following a similar comparison of PMEN3 and its
ancestral representatives (9A/1, 9V/5 and 9V/6; Table 2),
we identified nine PMEN3 genomic regions (4,662 to
22,104 bp, totalling 117,689 bp, approximately 5.3% of
the genome) that were identical to sequences from
PMEN1 or differed by only two nucleotides across 22,104
bp, and were different from those of the ancestral repre-
sentatives (Figure 2; Additional file 2). We suggest that
these regions were also acquired by PMEN3 from
PMEN1 through the process of recombination.
The CGSP14 and PMEN3 putative recombinogenic
regions contained 213 and 108 whole or part coding
sequences, respectively (Additional file 2). In addition to
the penicillin resistance-conferring pbp2x, pbp1a and
pbp2b genes, the following coding sequences associated
with enhanced virulence or colonization potential were
included: the CGSP14 bgaA, clpX, SPN23F_05810 and
SPN23F_20890 genes associated with enhanced host
colonization ability [24]; the CGSP14 virulence-asso-
ciated cbpJ, msmK, chloramphenicol acetyltransferase
and zeta toxin/epsilon antitoxin genes [25-27] (the latter
two of which are situated on the CGSP14 conjugative
transposon); and the PMEN3 virulence-associated cbpD,
cbpJ and clpC genes [26].
The possibility that the putative imported regions were
acquired by CGSP14 and PMEN3 from non-PMEN1
representative pneumococci cannot be ignored. However,
the majority, 13 and 6, respectively, of regions described
here were not identical among any of 96 additional pneu-
mococcal genomes, representing a diverse range of 31
independent CCs (listed in Additional file 3, excluding
23F/4 and CC66 isolates). Two and three of the regions,
respectively (Figure 2), were identical or highly similar
among isolates representing CC66, and so it is possible
that those regions may have been acquired from a CC66
Figure 1 pbp loci and flanking regions of the PMEN1 reference, CGSP14 and PMEN3 reference genomes. Red blocks indicate identical
nucleotide sequence with substitutions or single insertions marked by black lines. The relative positions of the pbp2x, pbp1a, and pbp2b loci are
shown, as are the two loci (dexB and aliA) flanking the capsular (cps) locus.
Figure 2 PMEN1 reference genome regions putatively acquired by CGSP14 and the PMEN3 reference. Putative recombination regions
marked by colored blocks and mapped to PMEN1 reference genome coordinates. Red blocks: regions identical or highly similar to that of the
PMEN1 reference only. Gray blocks: regions identical or highly similar to those of the PMEN1 reference and one or more CC66 representative(s).
Single nucleotide substitutions or insertions are marked with black lines. Origin of replication marked as ‘0’.
Wyres et al. Genome Biology 2012, 13:R103
http://genomebiology.com/2012/13/11/R103
Page 4 of 12
representative (also see Additional file 4). Although our
collection cannot capture the full complement of pneu-
mococcal genetic diversity, given these results and the
extremely high similarity of the putative import regions
to the PMEN1 genome, we believe that they originated
from a PMEN1 representative. Thus, these data suggest
that DNA originating from the PMEN1 clone has greatly
influenced the genomic evolution of at least two unre-
lated pneumococcal clones.
Ancestors of PMEN1
The Genome Comparator tool [28] was used to screen
104 pneumococcal genomes, representing a very diverse
range of CCs and serotypes (Additional file 3), for regions
of DNA (aside from the pbps) that were identical to
PMEN1. We identified 1,990 coding sequences from the
PMEN1 GenBank Accession NC_011900.1 file (totaling
1,833,672 bp, approximately 83% of the genome). Com-
parable coding sequences in the query genomes were
identified by BLASTn search if they shared ≥ 70%
nucleotide sequence identity and could be aligned at
100% length. Consequently, coding sequences spanning
the ends of assembly contigs could not be identified.
Surprisingly and uniquely, the analyses showed that
23F/4, the first PNSP isolated from Australia (Table 2),
was very likely to be an ancestral representative of
PMEN1, since approximately 95% of the identified coding
sequences were ≥ 98% similar to those of PMEN1.
Approximately 75% of identified coding sequences in
23F/4 were identical to PMEN1 and over one-third of the
coding sequences that were not identical differed by only
one or two nucleotide substitutions. The pbp2x, pbp1a,
and pbp2b genes and three of the seven MLST loci were
not identical. Additionally, a comparison of the PMEN1
and 23F/4 genomes, performed using the Artemis Com-
parison Tool [29] using all available sequence (both cod-
ing and non-coding sequence; Figure 3), clearly showed
three large regions of the PMEN1 genome that were par-
tially or completely missing from the 23F/4 genome and
were presumably acquired by a more recent ancestor of
PMEN1. These were the ICESp23FST81 element, the
ɸMMI phage and a Na+-dependent ATPase island, all
associated with increased colonization and virulence
potential [30-33].
The Genome Comparator analyses also revealed that
the majority (87, 83.6%) of genomes analyzed - represent-
ing 31 unique CCs and 30 serotypes - shared 15.1% ± 2
standard deviations (excluding 12 outliers with > 30%
identical coding sequences) of the identified coding
sequences identically with PMEN1 (Figure 4). We suggest
that these ‘baseline’ coding sequences were shared
through ancestral descent, that is, they were identical in
the most recent common ancestor of these clones and
have not undergone subsequent change. (For purposes of
Figure 3 Artemis Comparison Tool comparison of the PMEN1 reference and 23F/4 genomes. Red lines indicate homologous nucleotide
sequence matches. Blue lines indicate reverse complement nucleotide sequence matches. Black arrows indicate large regions present in the
PMEN1 reference genome but absent from the 23F/4 genome: (1) Na+-dependent ATPase island; (2) ICESp23FST81 element; and (3) ɸMMI phage.
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comparison, the same analysis was performed using
pneumococcal genome TIGR4 (GenBank accession
AE005672.3) as the reference and a similar baseline mean
level of identical sequence of 14.5% was observed (Addi-
tional file 5).
Isolates belonging to CC66 shared between 44.5% and
58.4% coding sequences identically with PMEN1. These
isolates included PSP and were dated from 1952, preced-
ing the estimated origin of PMEN1. Since the proportion
of identical coding sequences between CC66 and PMEN1
was much greater than between those of PMEN1 and the
other CCs represented here, we conclude that PMEN1
was ancestrally more closely related to CC66 than to
other CCs, which supports the findings of Donati and
colleagues [34] (also see Additional file 4).
Discussion
To our knowledge, our collection represents the largest
historical pneumococcal collection ever compiled and
includes the greatest number of early (1960s to 1980s)
PNSP in a single study. This has provided us with a
unique opportunity to study pneumococcal evolution.
Within our diverse isolate collection, whole or part pbp
alleles that were identical or highly similar to those of the
PMEN1 reference strain were identified from pneumo-
cocci representing a total of 24 distinct CCs. Two iso-
lates, CGSP14 and PMEN3, shared pbp2x, pbp1a and
pbp2b sequences identically with PMEN1, and shared
highly similar sequences in the pbp flanking regions. The
full extent of sharing all three of these PMEN1 pbp
sequences has never before been uncovered (nor have
the large regions around all three pbps), although pre-
vious authors have independently noted pbp similarities
between CGSP14, PMEN3, PMEN2 and PMEN1
[16,35-38]. Highly similar pbp2x and pbp2b nucleotide
sequences have also been independently identified
among numerous pneumococcal and viridans streptococ-
cal clones [37,39,40]. Shared resistance-conferring pbp
sequences other than those associated with PMEN1 have
also been described previously [5,41,42] and were identi-
fied among our isolate collection, though at much lower
frequency (data not shown). Additionally, data from
other authors have suggested that fluoroquinolone resis-
tance determinants have been donated from PMEN1 to
numerous unrelated pneumococcal clones [43].
It is very unlikely that identical or highly similar
sequences were assembled independently in different
CCs, but rather that they have been transferred, as whole
or part alleles, between unrelated pneumococcal clones
at least once for each independent CC. Note that the
establishment of defined CCs must have occurred prior
to acquisition of these pbp alleles, since we also identified
penicillin-susceptible members of these clones (that is,
CC1514, CC156/1629A/V).
The predominance of the PMEN1-like pbp sequences
within our isolate collection suggests that the PMEN1
Figure 4 Percentage PMEN1 reference coding sequences identified identically within 104 pneumococcal genomes. Points represent
independent pneumococcal isolates. Isolates representing CCs for which n ≥ 3 are labeled by CC. Isolates representing CCs for which n < 3 are
labeled as ‘Miscellaneous CCs’. Black line represents mean percentage identical coding sequences ± 2 standard deviations (gray lines). Isolates of
interest are labeled: (1) CGSP14; (2) USA18; (3) CDC2088-04; (4) PMEN3; (5) CDC3059-06; and (6) 23F/4 (also see Additional file 4).
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reference pbp2x, pbp1a and pbp2b sequence combina-
tion may provide an evolutionary selective advantage
over other resistance-conferring pbp alleles, which is
consistent with recent experimental data suggesting cer-
tain combinations of pbp2x and pbp1a alleles are more
advantageous than others [44]. A study of genomic evo-
lution within the PMEN1 lineage also provided evidence
consistent with the hypothesis that the pbp2x and
pbp1a alleles were positively selected [17]. pbp2x is
upstream and pbp1a is downstream of the capsular (cps)
locus in the pneumococcal genome. The authors noted
that the boundaries of recombination events affecting
the cps locus appeared to be restricted by the nearby
pbp2x and pbp1a loci. It is known that both of these
loci and the cps locus can be transferred simultaneously
between pneumococci [45], and thus the restriction
within the PMEN1 lineage is likely not entirely
mechanistic.
In addition to the pbp loci and flanking regions,
CGSP14 and PMEN3 acquired multiple genomic regions,
totaling approximately 9.5% and approximately 5.3% of
the genome, respectively, from PMEN1 representative(s).
This is consistent with two recent studies that demon-
strated that multiple fragment recombination had taken
place in vivo, between pneumococci isolated from a sin-
gle patient [46] and among vaccine escape strains isolated
in the USA [47]. The suggestion that a significant pro-
portion of the genome may be acquired from a single
pneumococcal donor was recently supported mechanisti-
cally by Attaeich and colleagues [48]. These authors
showed that cellular levels of pneumococcal SsbB protein
are sufficient to maintain an intracellular pool of interna-
lized DNA of up to 1.15 Mb of length (approximately
50% of the genome). Such a pool of genetic material,
potentially originating from a single donor cell, could
then be used for successive rounds of recombination.
We cannot know for certain whether the CGSP14 and
PMEN3 imported regions were acquired simultaneously
in a single event or via successive recombination events.
Either way, the data strongly suggest that they were
acquired from a PMEN1 representative. It should also be
noted that recombination events additional to those
described here, and involving acquisition of DNA from
other pneumococcal clones or other species, may also
have altered the CGSP14 and PMEN3 genomes.
The genomic regions acquired from the PMEN1 donor
may also have contributed to the virulence and host colo-
nization ability of the recipients. CGSP14 was multidrug-
resistant and isolated from a child suffering from necro-
tizing pneumonia complicated with hemolytic uremic
syndrome [35]. PMEN3 represents another globally dis-
tributed multidrug-resistant clone [15]. The putative
recombinogenic regions acquired by both of these pneu-
mococci included several genes associated with virulence
or host colonization potential. Interestingly, large sec-
tions of the CGSP14 transposon, which was shown pre-
viously to contain regions of similar sequence to those of
the PMEN1 ICESp23FST81 element [35], were in fact
identical to those of PMEN1. Two interpretations of the
regions of similarity within the ICESp23FST81 element
are possible. One is convergent evolution between
PMEN1 and CGSP14, with both strains independently
acquiring similar, recently diverged elements. Alterna-
tively, a more divergent element may have been acquired
by CGSP14 that was subsequently modified through
recombination with DNA from PMEN1. The mosaic nat-
ure of these variable conjugative elements [17] makes dis-
tinguishing these two hypotheses difficult.
Finally, we showed that one of the first reported PNSP
(23F/4) represented the ancestor of PMEN1. The year of
isolation of 23F/4 (1967) correlated with the predicted
date of emergence of the PMEN1 lineage (approximately
1970), although the country of isolation (Australia) did
not match the predicted region of PMEN1 origin (Eur-
ope) [17]. Despite its high overall genomic similarity to
PMEN1, the 23F/4 ST, which differed from that of
PMEN1, has not been identified amongst modern pneu-
mococci. Perhaps the differences between these two gen-
omes could explain the differences in disseminative
success of these two STs. The acquisition of more favor-
able pbp2x, pbp1a and pbp2b alleles in the PMEN1 gen-
ome provides a partial explanation; however, other
changes and/or acquisition of other loci have also likely
played an important role. The PMEN1 ICESp23FST81
element, Na+-dependent ATPase island and ɸMMI
phage were absent from the 23F/4 genome. The
ICESp23FST81 element carries both tetracycline and
chloramphenicol resistance determinants [30] plus a
umuDC-like gene shown to provide protection against
UV damage [32]. The Na+-dependent ATPase island and
a ɸMMI phage closely related to that of PMEN1 have
been associated with an increased incidence of invasive
pneumococcal disease [33] and increased cell adherence
capabilities [31], respectively.
Any or all of these regions may have provided PMEN1
with a selective advantage, allowing it to persist among
the greater pneumococcal population for the past three
decades. Alternatively, the combination of these regions
with the PMEN1 reference pbp genes and the 23F/4
genetic background may have been the most important
factor. In any case, the subsequent global dissemination
of PMEN1 likely aided the spread of its pbp alleles and
other regions of its genome to numerous unrelated pneu-
mococci. Some of the recipient pneumococci might sub-
sequently have transferred these PMEN1-like sequences
to additional pneumococcal clones.
Recently, through comparison of multiple representa-
tives within the PMEN1 CC, Croucher et al. [17] showed
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that the PMEN1 lineage contains a vast amount of
genetic diversity, largely resulting from horizontal acqui-
sition of DNA via recombination. Through comparison
of genomic sequences across a genetically diverse collec-
tion of pneumococci, our study has greatly increased our
understanding of the emergence of the PMEN1 clone
and its subsequent contribution to the genomic evolution
and spread of penicillin resistance determinants among
other pneumococci. It is well understood that many bac-
terial species, particularly the pneumococcus, frequently
undergo horizontal gene transfer; however, the direc-
tional genetic promiscuity described here, from a single
epidemiologically successful clone to numerous unrelated
clones, has not been demonstrated before in pneumo-
cocci, or other bacterial species as far as we are aware.
Antibiotics are among the most influential global pub-
lic health successes, but impose selective pressures that
drive bacterial genomic evolution. PMEN1 is an excellent
example of a bacterium that has become resistant to mul-
tiple antibiotics and that has evolved to become very suc-
cessful in colonization, transmission, and causing disease.
Moreover, PMEN1 has subsequently shared its advanta-
geous DNA with other unrelated pneumococci. Studies
such as this one may help to identify ways to counteract
these biological changes and preserve the value of anti-
biotics for the future.
Materials and methods
Strain collection
A unique collection of 426 global PSP and PNSP dated
1937 to 2007 was studied, as summarized in Table 1. Iso-
lates included one of the first PNSP reported from Aus-
tralia [6], the first high-level PNSP reported from South
Africa [8,9] and the 43 PMEN reference strains [15]. The
Statens Serum Institut, Denmark provided 211 pneumo-
cocci dated 1937 to 1996. These isolates included both
PSP (n = 203), PNSP (n = 7) and an isolate of unknown
penicillin susceptibility (n = 1). Following the analyses of
MLST and pbp sequence data from these isolates, the 43
PMEN clones (including both PSP (n = 18) and PNSP
(n = 25)) and additional modern (1990s to 2000s) PSP
(n = 38) and PNSP (n = 9) that had been recently geno-
typed by A Brueggemann/L McGee and represented CCs
of interest, were selected for inclusion. In addition, a lit-
erature search was performed to identify studies that
reported early PNSP. The authors of those papers were
contacted and isolates were requested; the majority of
isolates were still available and were added to our collec-
tion. The available isolates comprised PNSP dated 1969
and 1972 from Papua New Guinea (n = 2), PSP (n = 8)
and PNSP (n = 71) dated 1977 to 1989 from South
Africa, PSP (n = 1) and PNSP (n = 26) dated 1981 to
1991 from the USA, PNSP dated 1987 to 1989 (n = 9)
from Spain and PNSP dated 1986 to 1994 from Germany
(n = 8). Finally, genomic sequence data for 16 isolates
were retrieved from the GenBank database. These iso-
lates included both PSP (n = 5), PNSP (n = 4) and seven
pneumococci of unknown penicillin susceptibility. Sero-
type and penicillin susceptibility data are summarized by
decade in Additional file 6. Where not previously pub-
lished, isolates were serotyped by Quellung reaction and
penicillin minimum inhibitory concentrations were
obtained by Etest (bioMérieux Basingstoke, United King-
dom) as per the manufacturer’s guidelines.
DNA extraction
Single pneumococcal colonies were cultured on Colum-
bia agar with sheep blood (Oxoid Basingstoke, United
Kingdom) and incubated overnight at 37°C + 5% CO2.
Three to four sweeps of growth were subcultured onto
tryptic soy agar (Oxoid) with 1,000 U ml-1 catalase
(Oxoid) and spread with a swab before further overnight
incubation at 37°C and 5% CO2 (at Oxford); or cultured
in serum broth for 7 h (at the Statens Serum Institut).
Pneumococcal growth was suspended in 1 ml phosphate
buffered saline (pH 7.4; Fisher Bioreagents Loughbor-
ough, United Kingdom) and centrifuged at 7,600 rpm for
10 minutes. Extractions were completed using the
DNeasy kit (Qiagen, West Sussex, United Kingdom) as
per the manufacturer’s instructions.
MLST and clonal complex designation
Where not previously published (n = 352) multilocus
sequence types were determined for all isolates [49].
MLST data for all of our isolates and those deposited in
the pneumococcal MLST database [50] were analyzed by
the goeBURST [51] method to predict CC group and
sub-group founders. Isolates were assigned to CCs so
that only single/double locus variants of the group foun-
der and any additional single locus variants of large (n ≥
5 STs) sub-group founders were included. CCs were
named according to the predicted group founder(s) ST
(s). When goeBURST could not distinguish a group foun-
der the group was designated NoneX, where X was the
ST of lowest numerical value in the group. When isolates
could not be assigned to a CC due to a lack of closely
related STs, they were designated SingletonX, where X
was the isolate ST.
pbp profiling
pbp2x (1,673 bp), pbp1a (901 bp) and pbp2b (1,272 bp)
nucleotide sequences for 389 selected isolates were
retrieved from GenBank (n = 36 sequences) or deter-
mined by conventional PCR and Sanger sequencing (n =
1,131 sequences). We chose 174 of 211 isolates from the
Statens Serum Institut for pbp nucleotide sequencing
because they represented a wide range of serotypes, STs
and isolation dates. All isolates from each of the other
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sources were also included. PCR reactions containing 1 μl
DNA extract, 13.5 μl Hotstar Taq DNA Polymerase mas-
ter mix (Qiagen, West Sussex, United Kingdom), 0.5 μl
each of the forward and reverse primers (100 μM) (Addi-
tional file 7) were prepared to a final volume of 25 μl.
Cycling parameters were as follows: initial denaturation of
95°C for 180 s, followed by 35 (40 for pbp2x) cycles of 95°
C for 30 s, 55°C (58°C for pbp1a) for 30 s and 72°C for 60
s followed by a final extension period of 72°C for 10 min-
utes. Products were precipitated by 20% polyethylene gly-
colate/2.5 M NaCl, washed in 70% ethanol and rehydrated
in 10 to 20 μl nuclease-free H2O (Sigma Gillingham,
United Kingdom). Sequencing reactions containing 2 μl
rehydrated PCR product, 1.75 μl 5x sequencing buffer,
4 μl primer (1 μM) (Additional file 7) and 0.5 μl BigDye®
(Applied Biosystems, Paisley, United Kingdom) were pre-
pared in a final volume of 10 μl. Cycling parameters were
as follows: 25 cycles of 96°C for 10 s, 50°C for 5 s and 60°
C for 2 minutes. Sequencing products were precipitated
with 5 M sodium acetate (Sigma) solution, washed with
70% ethanol and subsequently separated and detected
with an ABI Prism 3730 automated DNA sequencer
(Applied Biosystems, Paisley, United Kingdom). Sequences
were aligned by MUSCLE [52] and imported to MEGA5
[53] for visual comparison. Unique pbp sequences were
assigned unique allele numbers.
Whole-genome sequencing
We selected 96 isolates for whole genome sequencing
(Additional file 3) using the following criteria. First, iso-
lates that were not closely related to PMEN1 based on
MLST data but shared identical pbp alleles or partial pbp
alleles to those of the PMEN1-reference strain. The
selected isolates were distributed through time, by geo-
graphic location and by genotype in order to capture the
greatest possible amount of genetic diversity. Second, iso-
lates representing CCs of interest (for example, major
international CCs) for which both historical and modern
isolate representatives were available. Inclusion of the
historical representatives was crucial, as it allowed us to
differentiate identical/highly similar sequence imports
obtained exogenously versus identical sequence due to
common ancestry. Within these CCs the selected isolates
were distributed through time, by geographic location, by
serotype and by pbp allele combination, in order to cap-
ture the greatest possible amount of genetic diversity.
DNA was extracted to a final concentration of 20 ng/μl
as described above. Sequencing was via the Illumina plat-
form as previously described [17]. As per standard proto-
cols, multiplex library construction with a 200 bp insertion
size was followed by 54 nucleotide paired-end sequencing.
Illumina reads were assembled to contigs using the Velvet
software [54]. Data for seven genomes were rejected based
on technical problems. K-mer lengths were optimized to
the maximum length achieving an average of ≥ 20× read
coverage across assemblies. Resulting contigs were
between 41 bp and 328,742 bp length (mean = 3,797 bp;
see Additional file 4 for further details). Contigs were
deposited in a BIGSdb database [28] and in the European
Nucleotide Archive (see Additional file 8 for accession
numbers). Contigs were ordered to the PMEN1 reference
genome using ABACAS [55] and viewed with the Artemis
Comparison Tool [29], allowing for the extraction of
selected sequence regions spanning > 1 contig.
Identification of recombination fragments from PMEN1
The BIGSdb Genome Comparator tool, which utilizes the
BLAST algorithm, was used to compare PMEN1 coding
sequences to those of CGSP14, PMEN3 and their respec-
tive predicted ancestral representatives (Table 2). Compar-
able coding sequences in the query genomes were
identified by BLASTn search if they shared ≥ 70% nucleo-
tide sequence identity (to allow for the identification of
variable sequences among conserved protein classes [28]
and to avoid bias towards sequence variants specific to
PMEN1) and could be aligned at 100% length (to ensure
that any coding sequences identified as identical to
PMEN1 were indeed identical across their entire length).
Potential recombination regions were indicated by coding
sequences shared identically by PMEN1 and CGSP14 or
PMEN3, but not by any of the respective ancestral repre-
sentatives. Sequence regions spanning the coding
sequences of interest plus 5 kb flanking either side were
extracted from the PMEN1, CGSP14, PMEN3 and ances-
tral representative genomes, aligned and imported into
MEGA5 [53] to produce variable site maps for visual
inspection (Additional file 9). Recombination regions were
classified as the maximum length of sequence over which
CGSP14 or PMEN3 were identical to PMEN1 but differ-
ent from their ancestral representatives.
Identification of PMEN1 ancestral representatives
Genome comparator was used to screen 104 isolates
(Additional file 3) representing 34 CCs and 31 serotypes
for coding sequences identical to those of the PMEN1
reference (parameters as above). 23F/4 was identified as
sharing a high percentage of coding sequences identically
with PMEN1 and was thus subjected to further analysis.
PMEN1 coding sequences that differed in 23F/4 were
extracted from the PMEN1 whole-genome sequence and
BLASTed against the 23F/4 Velvet contigs in the BIGSdb.
Sequences were aligned and percentage nucleotide differ-
ence was calculated. 23F/4 contigs were ordered against
the PMEN1 chromosome by ABACAS [55] and viewed
with the Artemis Comparison Tool [29] to identify geno-
mic regions present in PMEN1 but absent from 23F/4.
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Additional material
Additional file 1: Tables S1 to S3. Lists of the pbp allele sequence
regions that were identical or highly similar to those of the PMEN1
reference strain.
Additional file 2: Tables S4 and S5. Details of the regions of the
CGSP14 and PMEN3 genomes, respectively, that were identified as
putatively recombinogenic and acquired from PMEN1.
Additional file 3: Table S6. More information (for example, serotype
and penicillin susceptibility) about the isolates for which whole-genome
sequences were analyzed in this study.
Additional file 4: Supporting Results and Methods. More information
about MLST and pbp diversity, the imported regions of CGSP14 and
PMEN3, coding sequences found in both PMEN1 and isolates of CC66,
outlier isolates highlighted in Figure 4 and methodological details related
to whole-genome sequence assemblies.
Additional file 5: Figure S2. Depiction of the results of a Genome
Comparator analysis of 104 pneumococcal genomes compared to the
TIGR4 reference genome.
Additional file 6: Table S7. Summary of the 442 isolates included in
this study, stratified by era of isolation.
Additional file 7: Table S8. Details of the primers used for PCR and
conventional sequencing of regions of pbp2x, pbp1a and pbp2b.
Additional file 8: Table S9. Details of the metadata for the 442 isolates
included in this study.
Additional file 9: Figure S3. A variable site map of one PMEN3 putative
imported region and flanking regions.
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